Delivery Order SPE2DB24D1034-SPE2DB25FWAF5

Award Date 2/4/25
Potential Completion Date 2/5/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $8,538.80 firm fixed-price delivery order is for the supply of 4566133902 IPOL VIAL 5ML medical products, with an ultimate completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,486.05 firm fixed-price delivery order is for IPOL VIAL 5ML medical products. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,117.80 firm fixed price delivery order is for the supply of IPOL VIAL 5ML medical products. The contract has a period of performance through February 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is a delivery order worth $20,920.06 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, awarded by the Defense Logistics Agency (DLA). The contract is for the delivery of IPOL VIAL 5ML medical supplies with a performance period through September 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,163.64 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML pharmaceutical products. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order worth $2,047.30 and has a Firm Fixed Price pricing type. The contract is for the delivery of IPOL VIAL 5ML pharmaceutical products and has an ultimate completion date of April 24, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award, with an ID of SPE2DX15D3402|SPE2DX25F1KEZ, is a delivery order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, with Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,102.95 firm fixed-price contract is for the delivery of 4566760278 IPOL VIAL 5ML medical supplies, with a completion date of December 19, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award is a delivery order (SPE2DB22D2214|SPE2DB24FS5XB) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $83,478.76 Firm Fixed Price contract is for the supply of IPOL VIAL 5ML medical products, with a period of performance through July 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,280.82 firm fixed price delivery order is for the supply of 4565736275 ! IPOL VIAL 5ML medical products. This award is not associated with a set-aside program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,371.20 firm fixed-price delivery order contract is for the supply of IPOL VIAL 5ML medical products, with a completion date of February 24, 2023. This contract is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB25FWAF5
    Delivery Order

This federal contract award with ID SPE2DB24D1034|SPE2DB25FWAF5 was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The $2,180.20 firm fixed-price delivery order contract covers the supply of IPOL VIAL 5ML medical products to support federal healthcare programs.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. This specific delivery order is part of that broader IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 5/6/25, 11:01 AM